We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 197 results
  1. Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey

    Background

    Health authorities have struggled to increase vaccination uptake since the COVID-19 vaccines became available. However, there have been...

    Hoda Mahmoud Mohammad Abdulaziz, Marwa Ahmed Saleh, ... Alaa Abdel-Aziz Sabry in Journal of Nephrology
    Article Open access 02 March 2023
  2. The Effect of Combining the COVID-19 Vaccine with the Seasonal Influenza Vaccine on Reducing COVID-19 Vaccine Rejection Among Libyans

    Background

    Coronavirus disease 2019 (COVID-19) vaccine coverage remains low in Libya compared to other countries in the Eastern Mediterranean Region....

    Ramy Mohamed Ghazy, Malik Sallam, ... Mohamed Fakhry Hussein in Journal of Epidemiology and Global Health
    Article Open access 12 May 2023
  3. “How” Versus “Why” Messaging to Increase Uptake of Booster Vaccination Against COVID-19: Results of a Pragmatic Randomized Trial

    Background

    Messages aimed at increasing uptake of vaccines have been modestly successful, perhaps in part because they often focus on why individuals...

    Nancy Haff, Niteesh K. Choudhry, ... Julie C. Lauffenburger in Journal of General Internal Medicine
    Article 06 November 2023
  4. Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA

    Objective

    To assess the cost effectiveness of the second COVID-19 booster vaccination with different age groups.

    Methods

    We developed a...

    Rui Li, Pengyi Lu, ... Lei Zhang in Applied Health Economics and Health Policy
    Article 01 November 2023
  5. Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial

    Introduction

    The waning antibody levels several months after prime vaccination and the persistent epidemics of severe acute respiratory syndrome...

    Siyue Jia, **long Zhang, ... Fengcai Zhu in Infectious Diseases and Therapy
    Article Open access 01 December 2023
  6. Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines

    Vaccines have proven effective in protecting populations against COVID-19, including the recombinant COVID-19 vaccine (Sf9 cells), the first approved...

    Wenxin Luo, Jiadi Gan, ... Lei Chen in Signal Transduction and Targeted Therapy
    Article Open access 14 February 2024
  7. Trusted Information Sources About the COVID-19 Vaccine Vary in Underserved Communities

    The COVID-19 pandemic was one of the deadliest global public health events. In the United States, over 1.1 million individuals have died, and now...

    Brian R. Benson, Syed A. Rahman, ... Rolanda L. Ward in Journal of Community Health
    Article Open access 01 February 2024
  8. Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization

    COVID-19 inactivated vaccine-induced humoral responses in patients with lung cancer (LCs) to SARS-CoV-2 wild-type (WT) strain and variants BA.4/5...

    Chen Chen, Liyuan Dai, ... **aohong Han in Journal of Hematology & Oncology
    Article Open access 03 May 2023
  9. Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection

    Objective

    This study aimed to investigate the longitudinal circulating eosinophil (EOS) data impacted by the COVID-19 vaccine, the predictive role of...

    Zhuxian Zhu, Jixu Cai, ... Ziqiang Zhang in BMC Pulmonary Medicine
    Article Open access 22 May 2023
  10. Urological complications after COVID 19 vaccine according to age, sex and manufacturer

    Objectives

    To examine the effects of age, sex, and type of COVID-19 vaccine on urological complications after vaccination with COVID-19.

    ...
    Sung Ryul Shim, Kwang Taek Kim, ... Benjamin I. Chung in World Journal of Urology
    Article 03 July 2023
  11. A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine

    This study describes a SARS-CoV-2 outbreak caused by the Delta (B.1.617.2) variant in a nursing home in Central Italy during October–November 2021....

    Giancarlo Ripabelli, Michela Lucia Sammarco, ... Manuela Tamburro in Journal of Community Health
    Article 25 March 2022
  12. The global COVID-19 vaccine surplus: tackling expiring stockpiles

    Background

    A global surplus of coronavirus disease 2019 (COVID-19) vaccines exists as a result of difficulties in aligning the demand and supply for...

    Nguyen Khoi Quan, Nguyen Le My Anh, Andrew W. Taylor-Robinson in Infectious Diseases of Poverty
    Article Open access 20 March 2023
  13. Attitudes and personal beliefs about the COVID-19 vaccine among people with COVID-19: a mixed-methods analysis

    Background

    Little research is available regarding vaccination attitudes among those recently diagnosed with COVID-19. This is important to...

    Monica M. Bennett, Megan Douglas, ... Ann Marie Warren in BMC Public Health
    Article Open access 18 October 2022
  14. Comparison of COVID-19 vaccine policies and their effectiveness in Korea, Japan, and Singapore

    Background

    This study aimed to analyze coronavirus disease 2019 (COVID-19)vaccine policies and effectiveness in Korea, Japan, and Singapore, thereby...

    Mengyuan Ma, Leiyu Shi, ... Gang Sun in International Journal for Equity in Health
    Article Open access 20 October 2023
  15. Innovation-driven trend sha** COVID-19 vaccine development in China

    Confronted with the Coronavirus disease 2019 (COVID-19) pandemic, China has become an asset in tackling the severe acute respiratory syndrome...

    Yuntao Zhang, Yuxiu Zhao, ... **aoming Yang in Frontiers of Medicine
    Article 16 December 2023
  16. Vaccine effectiveness of COVID-19 and rebound in the real world

    We intend to evaluate the relationship between the rates of global SARS-CoV-2 vaccination and the number of COVID-19 confirmed cases, as well as the...

    Myung-Bae Park, Boram Sim in Clinical and Experimental Medicine
    Article 16 November 2023
  17. COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study

    Background

    The COVID-19 pandemic continues to have high caseloads in the US, with vaccines a critical component of the response. Disparities in...

    Wenting Huang, Emily Dove-Medows, ... Aaron J. Siegler in BMC Public Health
    Article Open access 12 January 2023
  18. Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients

    Background

    Vulnerable populations, such as hemodialysis (HD) patients and kidney transplant (RTx) recipients, have priority for anti-COVID-19...

    Maria Rosaria De Cagna, Vincenza Colucci, ... Marilina Tampoia in Clinical and Experimental Nephrology
    Article 16 February 2023
  19. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

    In the post-pandemic COVID-19 period, human activities have returned to normal and COVID-19 cases are usually mild. However, patients with multiple...

    Evangelos Terpos, Pellegrino Musto, ... Heinz Ludwig in Leukemia
    Article 04 May 2023
Did you find what you were looking for? Share feedback.